Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AGTR1 | P30556 | Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1 receptor) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Alzheimer diseaseArteries/arterioles disorderEssential hypertension | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| AGTR2 | P50052 | Type-2 angiotensin II receptor (Angiotensin II type-2 receptor) (AT2 receptor) | 7 | HypertensionNeuropathySecondary hypertension | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.53 | |||
| AMPE | Q07075 | Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249) | CD markersEnzymesPlasma proteins | 1 | Hypertension | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.53 | ||
| AMPN | P15144 | Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13) | CD markersEnzymesMetabolic proteins | 1 | Psoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| ANKL2 | Q86XL3 | Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4) | Disease related genesEssential proteinsHuman disease related genes | 1 | Primary microcephaly | Receptor-signaling mediation | 1 | 0.53 | ||
| ANO1 | Q5XXA6 | Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2) | Disease related genesFDA approved drug targetsPlasma proteins | 10 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.53 | |||
| ANO5 | Q75V66 | Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E) | Disease related genesHuman disease related genesPotential drug targets | 8 | Limb-girdle muscular dystrophyOsteogenesis imperfecta | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| APCD1 | Q8J025 | Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein) | 1 | Receptor-signaling mediation | 1 | 0.53 | ||||
| APLP1 | P51693 | Amyloid beta precursor like protein 1 (Amyloid beta (A4) precursor-like protein 1) (Amyloid-like protein 1) (APLP) (APLP-1) [Cleaved into: C30] | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.53 | |||
| AQP1 | P29972 | Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Channel-like integral membrane protein of 28 kDa) (Urine water channel) | Blood group antigen proteinsMetabolic proteinsPredicted membrane proteins | 6 | Lips/oral mucosa miscellaneous disorder | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.53 |